At the forefront of pharmaceutical innovation, Virupaksha stands out for its unwavering commitment to delivering excellence in manufacturing high-purity Fluconazole, a critical medication in the fight against cryptococcal meningitis. With certifications that underscore their dedication to quality and safety—such as WHO-GMP compliance and ISO 9001 for superior quality management systems alongside ISO 14001 for environmental stewardship—Virupaksha ensures that every batch produced meets stringent global standards.
Their state-of-the-art facilities are meticulously designed to uphold these standards, utilizing advanced technologies that enable precise control over production processes while minimizing environmental impact. This relentless pursuit of excellence not only reinforces their reputation as a trusted partner in healthcare but also significantly contributes to improving patient outcomes across diverse populations afflicted by this serious fungal infection.
Other Latest News
- Arrowhead Pharma inks global license & collaboration pact with Novartis for ARO─SNCA, a preclinical stage siRNA therapy against alpha─synuclein to treat synucleinopathies September 4, 2025 7:37 am Pharmabiz.com Arrowhead Pharmaceuticals, Inc., a company develops medicines that treat intractable diseases by silencing the genes that cause them, announced a global licensing and collaboration agreement with Novartis for ARO-SNCA, Arrowhead’s preclinical stage siRNA …
- Alginate Market to Reach USD 2,002.9 Mn by 2035, Driven by Expanding Demand in Food, Pharma, and Biomedical Applications September 4, 2025 7:28 am EIN Presswire Some of the leaders in this industry include Algaia Inc., Ashland Inc., CP Kelco Corporation, Danisco A/S Company (DuPont), Danisco A/S Company (DuPont). ROCKVILLE, MD , MD, UNITED STATES, September 4, 2025 /EINPresswire.com/ — The …
- Lung Cancer Liquid Biopsy Market Size to Triple, Reaching USD 3.54 Billion by 2034 on 13.2% CAGR Surge September 4, 2025 6:27 am EIN Presswire The global lung cancer liquid biopsy market was valued at approximately USD 1.02 billion in 2024 and is expected to reach around USD 3.54 billion by 2034 PUNE, MAHARASHTRA, INDIA, September 4, 2025 /EINPresswire.com/ — Lung cancer remains the …
- Synthetic Organic Alcohol Market Size to Surpass USD 21 Billion by 2034, Driven by Steady 4.7% CAGR September 4, 2025 5:45 am EIN Presswire The global synthetic organic alcohol market was valued at approximately USD 13.57 billion in 2024 and is expected to reach around USD 21.48 billion by 2034 PUNE, MAHARASHTRA, INDIA, September 4, 2025 /EINPresswire.com/ — Executive Summary …
- Karnataka pharma leaders outline vital skills for thriving in the sector and launching start-ups September 4, 2025 4:34 am Pharmabiz.com The pharma industry leaders in Karnataka noted that technical expertise remains foundational and the young qualified pharmacy professionals need to develop strategic thinking, regulatory awareness, and business acumen to thrive in a competitive and rapidly …
- MP pharma MSMEs exploring innovative 'pooling' strategy to navigate regulatory hurdles September 4, 2025 3:09 am Pharmabiz.com The small and medium-sized pharma enterprises (MSMEs) in Madhya Pradesh is exploring an innovative, collaborative ‘pooling’ strategy to navigate regulatory hurdles like the implementation of revised Schedule M. Faced with a severe lack of space and land …
- Bangladesh risks an Egypt-style collapse as Renata scandal erodes Yunus’s authority September 3, 2025 9:02 pm Weekly Blitz Bangladesh risks an Egypt-style collapse as Renata scandal erodes Yunus’s authority At a time when Muhammad Yunus and his interim regime in Bangladesh face mounting uncertainty, pharma-giant Renata Limited – which emerged in 1993 after Bangladeshi owners …
- Health Ministry to ease test licence, BA/BE study rules; pharma sector set to gain September 3, 2025 8:59 pm The Hindu Business Line In a major regulatory reform aimed at promoting ease of doing business in the pharma and clinical research sectors, the Union Health Ministry is planning top amend the New Drugs and Clinical Trials (NDCT) Rules, 2019. The most significant change proposed …
- Pharma Implications of Paul Offit’s Removal from Vaccine Advisory Committee September 3, 2025 6:41 pm Pharmaceutical Technology Major shifts in federal vaccine policy under Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. are reshaping the advisory landscape that underpins US vaccine approvals and immunization strategy (1). These developments could signal a more …
- Singapore-based firm proposes to acquire 25% in Welcure Drugs & Pharma September 3, 2025 5:55 pm The Economic Times Welcure Drugs & Pharmaceuticals Ltd on Wednesday said that Singapore-based Telexcell Trade has offered to acquire up to 25 per cent equity stake in the company at an indicative price of Rs 20 per share. This strategic investment is aimed at enhancing …
- From colonial trials to Covaxin: New book 'Vaccine Nation' traces India’s immunisation journey September 3, 2025 5:26 pm Hindustan Times New Delhi, A new book, "Vaccine Nation: How Immunization Shaped India", chronicles India’s transformation from a colonial testing ground in the 19th century to one of the world’s leading vaccine producers and immunisation success stories of the …
- UK pharma trade group pushes for overhaul of government evaluation of life sciences investments September 3, 2025 4:21 pm Fierce Pharma The U.K. is losing business opportunities in the life sciences sector because the government undervalues the economic and social benefits of investing in the manufacturing of innovative medicines, according to a report from the Cambridge Economic Policy …
- Universal Robots Announces Technicon as Global Certified Solution Partner in Pharmaceuticals September 3, 2025 3:47 pm Voice of Alexandria – Minnesota ODENSE, Denmark–(BUSINESS WIRE)–Sep 3, 2025– Universal Robots (UR), the world’s leading collaborative robot (cobot) company and a part of Teradyne Robotics, has today announced that long-time partner Technicon, one of the premier automation companies in …
- Handicraft, pharma, textile industries push for uniform GST amid US tariff row September 3, 2025 3:47 pm The Statesman (India) The handicraft industry in India has raised concerns over the imposition of 25% tariff by the United States along with an additional 25% tariff linked to the country’s purchase of Russian oil, even as the 56th meeting of the Goods and Services Tax (GST) …
- Syntegon delivers strong growth and EBITDA improvements in first half of 2025 September 3, 2025 3:12 pm World Pharma Today Successful growth strategy delivers sales growth in H1 of +11% versus prior year to €824m Strong growth momentum in the Pharma segment EBITDA up +41% to €127m, with margin expanding 300 bps to 15.5%.; all business units contributing Free cash flow €63m, + …
- Iktos hires tech industry veteran Dr Ashiq H Khan as Chief Business Officer to drive Global Growth & Pharma Partnerships September 3, 2025 1:36 pm EIN Presswire PARIS, FRANCE, September 3, 2025 /EINPresswire.com/ — Iktos, a global leader in AI-driven drug discovery, today announced the appointment of Dr. Ashiq H. Khan as Chief Business Officer (CBO) to spearhead the company’s global commercial expansion …
- Govt plans easing of clinical trial rules to attract global pharma, faster approvals likely September 3, 2025 1:07 pm The Indian Express With the government pushing for innovation and indigenous manufacturing in the pharmaceutical sector, the Union Health Ministry has proposed changes to the New Drugs and Clinical Trial Rules to ease regulatory approvals. The amendments would allow …
- Bullish Signals For Piramal Pharma: SEBI Analyst Flags Technical Breakout, Sees Over 10% Upside By October September 3, 2025 12:48 pm Asianet Newsable Piramal Pharma (PPL Pharma) shares surged 8% on Wednesday on the back of a positive brokerage note. JM Financial raised its earnings per share estimates for FY27 and FY28, assigning a 'Buy' rating to the stock and a revised target price of ₹313. …
- Kyphosis Treatment Market Set for Strong Growth as Demand for Advanced Spine Care Accelerates 2025 | DataM Intelligence September 3, 2025 12:30 pm EIN Presswire The Global Kyphosis Treatment Market is expected to reach at a CAGR of 6.2% during the forecast period 2024-2031. AUSTIN, TX, UNITED STATES, September 3, 2025 /EINPresswire.com/ — Overview of the Market: The Global Kyphosis Treatment Market …
- Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio September 3, 2025 12:25 pm EIN Presswire SARASOTA, FL, Sept. 03, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that IP Australia (the Australian Patent …
- 60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference September 3, 2025 12:02 pm EIN Presswire WASHINGTON, Sept. 03, 2025 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne diseases, announced today the …
- Cocrystal Pharma to Participate at the H.C. Wainwright Global Investment Conference September 3, 2025 12:00 pm EIN Presswire BOTHELL, Wash., Sept. 03, 2025 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a company overview at the H.C. Wainwright 27th Annual Global Investment …
- Paris-based ArcaScience raises €6 million to transform drug development with AI-powered benefit-risk intelligence September 3, 2025 11:26 am EU Startups ArcaScience, a French AI Healthtech startup setting a new standard for benefit-risk evaluation to make better, safer drugs, has announced a €6 million Seed funding round to support US and UK expansion, launch a patient-facing solution for paediatric brain …
- Lupin receives US FDA approval for risperidone long-acting injectable, with 180-day CGT exclusivity September 3, 2025 11:17 am Pharmabiz.com Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for risperidone for extended-release injectable suspension, 25 mg …
- Union Health Ministry Moves to Amend NDCT Rules 2019, Simplifying… September 3, 2025 9:23 am The Impressive Times BA/BE Study Applications: Certain categories can start after simple intimation to CDSCO—no licence needed. New Delhi- In line with the vision of Prime Minister Narendra Modi to reduce regulatory burden and promote Ease of Doing Business in the …
